Ismael Herruzo

949 total citations
16 papers, 509 citations indexed

About

Ismael Herruzo is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Ismael Herruzo has authored 16 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Ismael Herruzo's work include Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Ismael Herruzo is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers) and Bladder and Urothelial Cancer Treatments (5 papers). Ismael Herruzo collaborates with scholars based in Spain and United Kingdom. Ismael Herruzo's co-authors include A. Hervás, Víctor Macías, María José Ortiz, Montse Ferrer, Alfonso Mariño, Ferrán Guedea, José Francisco Suárez, Ferrán Aguiló, Pablo Fernández and Javier Ponce de León and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Ismael Herruzo

16 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ismael Herruzo Spain 9 367 121 113 97 65 16 509
Alfonso Mariño Spain 11 389 1.1× 171 1.4× 130 1.2× 99 1.0× 51 0.8× 18 609
Lani Ignacio United States 12 275 0.7× 89 0.7× 114 1.0× 82 0.8× 32 0.5× 18 429
Wee Loon Ong Australia 13 317 0.9× 146 1.2× 104 0.9× 120 1.2× 40 0.6× 74 505
Alfred H. Brandon United States 10 237 0.6× 147 1.2× 117 1.0× 23 0.2× 41 0.6× 15 410
Sophie D. Fosså Norway 8 244 0.7× 136 1.1× 126 1.1× 65 0.7× 47 0.7× 10 400
Mark S. Austenfeld United States 12 518 1.4× 229 1.9× 144 1.3× 44 0.5× 109 1.7× 17 762
Heather Payne United Kingdom 10 361 1.0× 115 1.0× 131 1.2× 36 0.4× 16 0.2× 28 558
Jacqueline A Routledge United Kingdom 11 125 0.3× 92 0.8× 139 1.2× 64 0.7× 20 0.3× 20 342
K. Spearman United States 4 195 0.5× 67 0.6× 65 0.6× 28 0.3× 27 0.4× 4 288
Pablo Fernández Spain 6 314 0.9× 79 0.7× 94 0.8× 71 0.7× 42 0.6× 7 380

Countries citing papers authored by Ismael Herruzo

Since Specialization
Citations

This map shows the geographic impact of Ismael Herruzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ismael Herruzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ismael Herruzo more than expected).

Fields of papers citing papers by Ismael Herruzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ismael Herruzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ismael Herruzo. The network helps show where Ismael Herruzo may publish in the future.

Co-authorship network of co-authors of Ismael Herruzo

This figure shows the co-authorship network connecting the top 25 collaborators of Ismael Herruzo. A scholar is included among the top collaborators of Ismael Herruzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ismael Herruzo. Ismael Herruzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Garín, Olatz, José Francisco Suárez, Cristina Gutiérrez, et al.. (2023). Comparative effectiveness of new treatment modalities for localized prostate cancer through patient-reported outcome measures. Clinical and Translational Radiation Oncology. 44. 100694–100694. 2 indexed citations
2.
Garín, Olatz, José Francisco Suárez, Ferrán Guedea, et al.. (2020). Comparative Effectiveness Research in Localized Prostate Cancer: A 10-Year Follow-up Cohort Study. International Journal of Radiation Oncology*Biology*Physics. 110(3). 718–726. 8 indexed citations
3.
Molina, David, Julián Pérez-Beteta, Carlos López, et al.. (2016). Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survival. British Journal of Radiology. 89(1064). 20160242–20160242. 51 indexed citations
4.
Expósito, José, Ismael Herruzo, J. A. Medina, et al.. (2015). Evaluation of the utilization of external radiotherapy in the treatment of localized prostate cancer in Andalusia, Spain. Radiation Oncology. 10(1). 265–265. 1 indexed citations
5.
Torrecilla, J. López, A. Hervás, A. Zapatero, et al.. (2015). Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance. Reports of Practical Oncology & Radiotherapy. 20(4). 259–272. 13 indexed citations
6.
Arias, Fernando, Ismael Herruzo, Jorge Contreras, et al.. (2014). Postsurgical erlotinib and cisplatin concurrent chemoradiotherapy (CRT) promotes favorable outcomes in high-risk locally advanced head and neck squamous-cell cancer (LAHNSCC): A GICOR Working Group trial.. Journal of Clinical Oncology. 32(15_suppl). 6067–6067. 1 indexed citations
7.
Ferrer, Montse, Ferrán Guedea, José Francisco Suárez, et al.. (2013). Quality of life impact of treatments for localized prostate cancer: Cohort study with a 5year follow-up. Radiotherapy and Oncology. 108(2). 306–313. 62 indexed citations
8.
Torrecilla, J. López, et al.. (2012). Should the prescription of oral anticancer drugs be restricted?. Reports of Practical Oncology & Radiotherapy. 17(4). 187–189. 2 indexed citations
9.
Zapatero, A., et al.. (2012). Practice patterns in the management of prostate cancer in Spain: results from a national survey among radiation oncologists in 2009. Clinical & Translational Oncology. 15(3). 226–232. 2 indexed citations
10.
Guinot, José Luis, et al.. (2012). Consensus on treatment of endometrium carcinoma with brachytherapy. Clinical & Translational Oncology. 14(4). 263–270. 14 indexed citations
11.
Herruzo, Ismael, et al.. (2011). The White Book of Radiation Oncology in Spain. Clinical & Translational Oncology. 13(6). 385–395. 6 indexed citations
12.
Pardo, Yolanda, Ferrán Guedea, Ferrán Aguiló, et al.. (2010). Quality-of-Life Impact of Primary Treatments for Localized Prostate Cancer in Patients Without Hormonal Treatment. Journal of Clinical Oncology. 28(31). 4687–4696. 160 indexed citations
13.
Ferrer, Montse, Olatz Garín, J. Pera, et al.. (2009). Evaluación de la calidad de vida de los pacientes con cáncer de próstata localizado: validación de la versión española del cuestionario EPIC. Medicina Clínica. 132(4). 128–135. 23 indexed citations
14.
Ferrer, Montse, José Francisco Suárez, Ferrán Guedea, et al.. (2008). Health-Related Quality of Life 2 Years After Treatment With Radical Prostatectomy, Prostate Brachytherapy, or External Beam Radiotherapy in Patients With Clinically Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 72(2). 421–432. 138 indexed citations
15.
Cobo, Manuel, Silvia Gil, Ismael Herruzo, et al.. (2006). Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer. Clinical & Translational Oncology. 8(12). 903–911. 20 indexed citations
16.
Contreras, Jorge, et al.. (2006). Damage assessment in gastric cancer treatment with adjuvant radiochemotherapy: calculation of the NTCP’s from the differential HDV of the organs at risk. Clinical & Translational Oncology. 8(4). 271–278. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfonso Mariño Breakdown of academic impact, for papers by Lani Ignacio Breakdown of academic impact, for papers by Wee Loon Ong Breakdown of academic impact, for papers by Alfred H. Brandon Breakdown of academic impact, for papers by Sophie D. Fosså Breakdown of academic impact, for papers by Mark S. Austenfeld Breakdown of academic impact, for papers by Heather Payne Breakdown of academic impact, for papers by Jacqueline A Routledge Breakdown of academic impact, for papers by K. Spearman Breakdown of academic impact, for papers by Pablo Fernández
Rankless by CCL
2026